The first-ever cancer clinic on an American Indian reservation may close–unless CMS changes payment rules

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

The White House Office of Management and Budget has published a “Regulation for Federal Financial Assistance,” a proposed rule that seeks to fundamentally redraw the ground rules for all federally funded research. On the other side are America’s scientists who aren’t just crying foul—they are readying for a political fight.

Federal judge blocks Trump policy to charge $100,000 fee for H1-B visas

Judge Leo Sorokin, of the U.S. District Court for the District of Massachusetts, struck down a new policy under the Trump administration that tacks on a $100,000 fee for H1-B visas, which allows foreign nationals in “specialty occupations” to live and work in the U.S. The fee was previously $5,000 to $10,000.

ACA Marketplace enrollment estimated to fall by 17%, KFF analysis finds

As many as five million people may fall out of coverage on the Affordable Care Act Marketplace this year, according to an analysis from Kaiser Family Foundation and Wakely Consulting Group. The estimate projects enrollment to decline from 22.3 million people to 17.5 million.

Supreme Court rejects pharma challenges against CMS drug price negotiating powers

The U.S Supreme Court has declined to hear a slew of legal challenges filed by pharmaceutical companies such as AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Novo Nordisk, Novartis, and Boehringer Ingelheim.

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

Unfold AI, an AI prostate cancer mapping and clinical decision support platform, is now included in Medicare’s Physician Fee Schedules across the West Coast and Mountain West regions. The regional expansion of Medicare payment for the tool gives urologists and care teams clearer reimbursement pathways in physician office settings, an area that has historically lagged behind hospital outpatient settings for emerging technologies.

May 01, 2026

Vol.52 No.17

Cancer Policy

FDA and CMS announce RAPID coverage pathway aimed at accelerating patient access to some Breakthrough medical devices

The Centers for Medicare and Medicaid Services and FDA announced a new coverage pathway—called the Regulatory Alignment for Predictable and Immediate Device, or RAPID pathway—designed to expedite access to certain FDA-designated Class II and Class III Breakthrough devices for people with Medicare.

April 24, 2026

Vol.52 No.16

The first-ever cancer clinic on an American Indian reservation may close–unless CMS changes payment rules

YOU MAY BE INTERESTED IN

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

Federal judge blocks Trump policy to charge $100,000 fee for H1-B visas

ACA Marketplace enrollment estimated to fall by 17%, KFF analysis finds

Supreme Court rejects pharma challenges against CMS drug price negotiating powers

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

FDA and CMS announce RAPID coverage pathway aimed at accelerating patient access to some Breakthrough medical devices

Renew today!

Subscriber content

Never miss an issue!

Login

The first-ever cancer clinic on an American Indian reservation may close–unless CMS changes payment rules

YOU MAY BE INTERESTED IN

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

Federal judge blocks Trump policy to charge $100,000 fee for H1-B visas

ACA Marketplace enrollment estimated to fall by 17%, KFF analysis finds

Supreme Court rejects pharma challenges against CMS drug price negotiating powers

Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule

FDA and CMS announce RAPID coverage pathway aimed at accelerating patient access to some Breakthrough medical devices

Never miss an issue!

Login

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”